Matches in Wikidata for { <http://www.wikidata.org/entity/Q38026916> ?p ?o ?g. }
- Q38026916 description "article científic" @default.
- Q38026916 description "article scientifique" @default.
- Q38026916 description "articol științific" @default.
- Q38026916 description "articolo scientifico" @default.
- Q38026916 description "artigo científico" @default.
- Q38026916 description "artigo científico" @default.
- Q38026916 description "artigo científico" @default.
- Q38026916 description "artikel ilmiah" @default.
- Q38026916 description "artikull shkencor" @default.
- Q38026916 description "artículo científico" @default.
- Q38026916 description "artículu científicu espublizáu en 2012" @default.
- Q38026916 description "bilimsel makale" @default.
- Q38026916 description "scienca artikolo" @default.
- Q38026916 description "scientific article published on 05 October 2012" @default.
- Q38026916 description "scientific article published on 05 October 2012" @default.
- Q38026916 description "scientific article published on 05 October 2012" @default.
- Q38026916 description "vedecký článok" @default.
- Q38026916 description "vetenskaplig artikel" @default.
- Q38026916 description "videnskabelig artikel" @default.
- Q38026916 description "vitenskapelig artikkel" @default.
- Q38026916 description "vitskapeleg artikkel" @default.
- Q38026916 description "vědecký článek" @default.
- Q38026916 description "wetenschappelijk artikel" @default.
- Q38026916 description "wissenschaftlicher Artikel" @default.
- Q38026916 description "наукова стаття, опублікована в жовтні 2012" @default.
- Q38026916 description "научная статья" @default.
- Q38026916 description "научни чланак" @default.
- Q38026916 description "מאמר מדעי" @default.
- Q38026916 description "مقالة علمية نشرت في 05 أكتوبر 2012" @default.
- Q38026916 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38026916 name "Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma" @default.
- Q38026916 name "Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma" @default.
- Q38026916 name "Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma" @default.
- Q38026916 type Item @default.
- Q38026916 label "Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma" @default.
- Q38026916 label "Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma" @default.
- Q38026916 label "Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma" @default.
- Q38026916 prefLabel "Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma" @default.
- Q38026916 prefLabel "Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma" @default.
- Q38026916 prefLabel "Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma" @default.
- Q38026916 P1433 Q38026916-07956343-4401-4C70-95C0-E58F4B8FE9BB @default.
- Q38026916 P1476 Q38026916-D3173EF7-F10A-4681-B7D9-890499052BAE @default.
- Q38026916 P2093 Q38026916-070F8657-2E9D-4EC7-ADCB-74AE4565AD93 @default.
- Q38026916 P2093 Q38026916-0D9BA33A-0B48-4972-A9F8-6A3328AB2C39 @default.
- Q38026916 P2093 Q38026916-2C95BBE4-A75E-40FA-8512-FCBDB12D8045 @default.
- Q38026916 P2093 Q38026916-A5476D71-03B0-4380-A87E-29398EC56FBB @default.
- Q38026916 P2093 Q38026916-FEE518DF-9C97-4E61-B4CE-BBEFFB25BC26 @default.
- Q38026916 P2860 Q38026916-0074A9E9-81C1-40FC-A71C-B058B6CFBEEE @default.
- Q38026916 P2860 Q38026916-03F69E2E-DD69-4632-8B11-75217FDF1CD2 @default.
- Q38026916 P2860 Q38026916-0EB74152-26F4-4AA1-AFB7-C61EE162C7A7 @default.
- Q38026916 P2860 Q38026916-1FCF3FB1-5AE6-4C1C-ACA1-902E260375BE @default.
- Q38026916 P2860 Q38026916-377BFC80-53AA-4556-86AE-346E5B0BF880 @default.
- Q38026916 P2860 Q38026916-37E7B9C2-26CB-4139-BDE8-CEE14AE997C7 @default.
- Q38026916 P2860 Q38026916-45CDA81C-D797-4798-BB94-A619171C714D @default.
- Q38026916 P2860 Q38026916-54812C6D-B8FB-422E-A22C-5C58E6F05CF8 @default.
- Q38026916 P2860 Q38026916-6368CC81-08AB-4139-8CDA-056916095505 @default.
- Q38026916 P2860 Q38026916-70648992-07BF-47B0-9AD2-4B5B48483947 @default.
- Q38026916 P2860 Q38026916-7C3561DC-ABCA-4740-BDBD-337D381BD0C1 @default.
- Q38026916 P2860 Q38026916-8CF0E95F-73ED-4EF5-8647-8E3EEA59688C @default.
- Q38026916 P2860 Q38026916-961C8201-EAB8-4961-B90E-8C764A8048C4 @default.
- Q38026916 P2860 Q38026916-9E59AE58-46AB-4F54-9968-7215DD3FD0E4 @default.
- Q38026916 P2860 Q38026916-A49F8FCB-6185-461D-B045-570B998AE859 @default.
- Q38026916 P2860 Q38026916-A99C1760-2A9F-4635-9EAE-162843ECCCB7 @default.
- Q38026916 P2860 Q38026916-C1756348-79D5-4F7A-9A7F-65F39A39E000 @default.
- Q38026916 P2860 Q38026916-C279017D-DDD0-45DE-9251-EFD9B7A822D8 @default.
- Q38026916 P2860 Q38026916-C6678E99-3989-48D6-87EA-30E720445DEE @default.
- Q38026916 P2860 Q38026916-D043545F-B816-438B-8652-6300C18D4DEF @default.
- Q38026916 P2860 Q38026916-D33665D2-41BC-4391-BC2E-4E94F48A9748 @default.
- Q38026916 P2860 Q38026916-DD9F006A-0BD4-4FE2-B0D8-A2457FE3193F @default.
- Q38026916 P2860 Q38026916-EFFD296E-DE92-44D3-9BB9-6475132AAC40 @default.
- Q38026916 P2860 Q38026916-F821B95A-457D-4D84-BB48-FA47B6E6E870 @default.
- Q38026916 P304 Q38026916-7103EE44-1658-4503-ABBA-B00DC497FD54 @default.
- Q38026916 P31 Q38026916-8741E38B-9A67-4D9C-82BB-7169E09F9865 @default.
- Q38026916 P356 Q38026916-5F04F11F-567D-4EF1-87B4-600754949F1D @default.
- Q38026916 P407 Q38026916-B3FE0D72-6AE1-4B62-BAEE-08B16DD7D1F8 @default.
- Q38026916 P433 Q38026916-0245404B-77A5-4DAF-BA26-85640DA5169F @default.
- Q38026916 P478 Q38026916-83DAB901-F56B-46B8-902F-F91C452646D6 @default.
- Q38026916 P50 Q38026916-6B61673E-A90E-4E7F-BB9F-CF29046D838B @default.
- Q38026916 P50 Q38026916-82217737-2C73-48F5-8618-1AD047FD8418 @default.
- Q38026916 P50 Q38026916-C3ABBBEC-0C6B-4209-B901-7ECCBDA8CA53 @default.
- Q38026916 P577 Q38026916-A4F30E55-731F-46DB-A135-54F8E6691558 @default.
- Q38026916 P5875 Q38026916-37C727BC-7CA6-4618-BA5D-86AFFF2846D2 @default.
- Q38026916 P698 Q38026916-9C3374B4-35EE-4AFC-809F-27A3567B8580 @default.
- Q38026916 P921 Q38026916-76792F6C-CA50-44FC-8F97-E489181EE2D1 @default.
- Q38026916 P356 J.1365-2133.2012.11155.X @default.
- Q38026916 P698 22804352 @default.
- Q38026916 P1433 Q4970191 @default.
- Q38026916 P1476 "Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma" @default.
- Q38026916 P2093 "R F Kefford" @default.
- Q38026916 P2093 "R M Anforth" @default.
- Q38026916 P2093 "R Sharma" @default.
- Q38026916 P2093 "S Kossard" @default.
- Q38026916 P2093 "T C M P Blumetti" @default.
- Q38026916 P2860 Q24298749 @default.
- Q38026916 P2860 Q24631953 @default.
- Q38026916 P2860 Q27659493 @default.
- Q38026916 P2860 Q27851801 @default.
- Q38026916 P2860 Q27860458 @default.
- Q38026916 P2860 Q29614803 @default.
- Q38026916 P2860 Q29616828 @default.